LEGOO (ENDOVASCULAR OCCLUSION GEL) INJECTION UNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 00,01,03,05 report with the FDA on 2013-01-15 for LEGOO (ENDOVASCULAR OCCLUSION GEL) INJECTION UNK manufactured by Pluromed Inc..

Event Text Entries

[3368691] Doppler signal not satisfactory (poor blood flow) [directional doppler flow tests abnormal]. Undissolved polymer plug [device issue]. Case description: literature-spontaneous report was received on 12/12/2012 from an author regarding a patient (demographics not provided), initials unknown. This report was from a literature article entitled "a novel reverse thermosensitive polymer to archive temporary atraumatic vessel occlusion in infra-popliteal bypasses". The patient's medical history was significant for severe leg ischemia. On an unspecified date, the patient received legoo injection, intravascularly locally, one syringe of 1 ml for distal vessel control during infra-popliteal bypass surgery in severe leg ischemia. The lot number for legoo was not provided. On an unspecified date, doppler signals on the target vessel distal to the anastomoses were not satisfactory (poor blood flow). The patient's intra-operative angiography was performed. This showed evidence of run-off occlusion potentially due to the remaining intra-arterial polymer plug. Fogartys catheter was used to retrieve the undissolved polymer drug and the patient's back flow was successfully re-established. The action taken with legoo was not provided. Relevant concomitant medications were not provided. The reporter assessed the casual relationship between legoo and both the events as possible.
Patient Sequence No: 1, Text Type: D, B5


[10354100] Additional information was received on 12/17/2012 in the form of a qa investigation. Evaluation summery: as no lot number was provided, a lot investigation could not be performed. Manufacturer's comment: the benefit-risk relationship of legoo is not affected by this report. Journal: european journal of vascular and endovascular surgery. Author: mani k, campbell a, fitzpatrick j et al. Title: a novel reverse thermosensitive polymer to achieve temporary atraumatic vessel occlusion in infra-popliteal bypasses. Year: 2012, pages: 1-5.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3008867907-2012-00003
MDR Report Key2922226
Report Source00,01,03,05
Date Received2013-01-15
Date of Report2012-12-12
Date Mfgr Received2012-12-12
Date Added to Maude2013-02-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactBRUNO MENDEZ
Manufacturer Street675 WEST KENDALL STREET
Manufacturer CityCAMBRIDGE MA 02142
Manufacturer CountryUS
Manufacturer Postal02142
Manufacturer Phone6177686173
Manufacturer G1PLUROMED INC.
Manufacturer Street175 NEW BOSTON STREET
Manufacturer CityWOBURN MA 01801
Manufacturer CountryUS
Manufacturer Postal Code01801
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLEGOO (ENDOVASCULAR OCCLUSION GEL) INJECTION
Generic NameENDOVASCULAR OCCLUSION GEL
Product CodeOBC
Date Received2013-01-15
Model NumberUNK
Catalog NumberUNK
Lot NumberUNK
ID NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerPLUROMED INC.
Manufacturer AddressWOBURN MA US


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2013-01-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.